From November 18 to 19, 2024, the National Agency of Pharmaceutical Products organized a training session given by Dr. Ingrid KLINGMANN, President of the European Forum for Good Clinical Practice (EFGCP), on the ICH E3 guideline ‘Structure and Content of Clinical Study Reports’.

This session, dedicated to the Agency’s executives and experts, focused on the general principles of clinical development and its good practices, as well as on the structure and content of a clinical report, according to the ICH E3 guideline.